tradingkey.logo

Zimmer Biomet Holdings Inc

ZBH
查看詳細走勢圖
90.805USD
+0.275+0.30%
收盤 12/30, 16:00美東報價延遲15分鐘
18.00B總市值
22.40本益比TTM

Zimmer Biomet Holdings Inc

90.805
+0.275+0.30%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+0.30%

5天

+1.54%

1月

-6.89%

6月

-0.44%

今年開始到現在

-14.03%

1年

-13.85%

查看詳細走勢圖

TradingKey Zimmer Biomet Holdings Inc股票評分

單位: USD 更新時間: 2025-12-30

操作建議

Zimmer Biomet Holdings Inc當前公司基本面數據相對健康,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名36/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價103.16。中期看,股價處於平穩狀態。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Zimmer Biomet Holdings Inc評分

相關信息

行業排名
36 / 207
全市場排名
108 / 4560
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 30 分析師
持有
評級
103.158
目標均價
+11.22%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Zimmer Biomet Holdings Inc亮點

亮點風險
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入7.68B美元
高分紅
公司屬於高分紅公司,最新股息支付率21.51%
估值低估
公司最新PE估值22.40,處於3年歷史低位
機構減倉
最新機構持股195.45M股,環比減少0.31%
布蘭德斯投資公司持倉
明星投資者布蘭德斯投資公司持倉,最新持倉15.49K股

Zimmer Biomet Holdings Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Zimmer Biomet Holdings Inc簡介

Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.
公司代碼ZBH
公司Zimmer Biomet Holdings Inc
CEOTornos (Ivan)
網址https://www.zimmerbiomet.com/en

常見問題

Zimmer Biomet Holdings Inc(ZBH)的當前股價是多少?

Zimmer Biomet Holdings Inc(ZBH)的當前股價是 90.805。

Zimmer Biomet Holdings Inc 的股票代碼是什麼?

Zimmer Biomet Holdings Inc的股票代碼是ZBH。

Zimmer Biomet Holdings Inc股票的52週最高點是多少?

Zimmer Biomet Holdings Inc股票的52週最高點是114.440。

Zimmer Biomet Holdings Inc股票的52週最低點是多少?

Zimmer Biomet Holdings Inc股票的52週最低點是85.330。

Zimmer Biomet Holdings Inc的市值是多少?

Zimmer Biomet Holdings Inc的市值是18.00B。

Zimmer Biomet Holdings Inc的淨利潤是多少?

Zimmer Biomet Holdings Inc的淨利潤為903.80M。

現在Zimmer Biomet Holdings Inc(ZBH)的股票是買入、持有還是賣出?

根據分析師評級,Zimmer Biomet Holdings Inc(ZBH)的總體評級為持有,目標價格為103.158。

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是多少

Zimmer Biomet Holdings Inc(ZBH)股票的每股收益(EPS TTM)是4.053。
KeyAI